GAS5-inhibited Hepatocyte Pyroptosis Contributes to Hepatic Stellate Cell Inactivation Via MicroRNA-684 and AHR
Overview
Authors
Affiliations
Hepatocyte pyroptosis has been shown to be involved in liver damage progression. Previously, we found that growth arrest-specific 5 (GAS5) is a regulator of hepatic stellate cell (HSC) activation. However, whether GAS5 plays a role in hepatocyte pyroptosis remains unclear. In this study, reduced GAS5 was shown in CCl-treated mice and restoration of GAS5-inhibited liver fibrosis . Hepatocyte pyroptosis participated in the effects of GAS5-inhibited liver fibrosis, associated with reduced caspase-1, NLRP3, and IL-1β (hepatocyte pyroptosis markers). Notably, AHR expression, a suppressor of NLRP3, was enhanced by GAS5. Silencing AHR inhibited GAS5-mediated hepatocyte pyroptosis. GAS5 and AHR were targets of microRNA-684 (miR-684). In addition, the effects of GAS5 on hepatocyte pyroptosis could be inhibited by miR-684. Interestingly, GAS5-mediated hepatocyte pyroptosis contributed to HSC inactivation. In conclusion, we demonstrate that GAS5 inhibits hepatocyte pyroptosis and HSC activation, at least in part, via regulation of miR-684 and AHR.
Pyroptosis in health and disease: mechanisms, regulation and clinical perspective.
Liu Y, Pan R, Ouyang Y, Gu W, Xiao T, Yang H Signal Transduct Target Ther. 2024; 9(1):245.
PMID: 39300122 PMC: 11413206. DOI: 10.1038/s41392-024-01958-2.
Wang R, Gao Y Transl Pediatr. 2024; 12(12):2107-2120.
PMID: 38197105 PMC: 10772835. DOI: 10.21037/tp-23-424.